Kai Wille

COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

Maria Madeleine Rüthrich, Clemens Gießen-Jung, Stefan Borgmann et al. · Annals of Hematology · 2020 · 180 citations · Full text

Medicine, Infectious Diseases, Oncology +17

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group

Thomas Seufferlein, Waldemar Uhl, Marko Kornmann et al. · Annals of Oncology · 2022 · 160 citations · Full text

Medicine, Oncology, Surgery +11

Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).

Jens Hoeppner, Thomas Brunner, Florian Lordick et al. · Journal of Clinical Oncology · 2024 · 93 citations · Full text

Medicine, Oncology, Surgery +16

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli et al. · Leukemia · 2019 · 91 citations · Full text

Medicine, Hematology, Oncology +16

First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”

Carolin Jakob, Stefan Borgmann, Fazılet Duygu et al. · Infection · 2020 · 77 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15